top of page
2024
Study of Late-Onset Stargardt Type 1 disease: Characteristics, Genetics and Progression
Catherina HZ Li, Jeroen AAH Pas, Zelia Corradi, Rebekkah J Hitti-Malin, Anne Hoogstede, Esmee H Runhart, Patty PA Dhooge, Rob WJ Collin, Frans PM Cremers, Carel B Hoyng
Ophthalmology, 131: 87-97
2023
Generation of an induced pluripotent stem cell line carrying biallelic deletions (SCTCi019-B) in ALDH7A1 using CRISPR/Cas9
Imke M E Schuurmans, Ka M Wu, Clara D M van Karnebeek, Nael Nadif Kasri, Alejandro Garanto
Stem Cell Res, 71: 103173
Generation of an induced pluripotent stem cell line carrying biallelic deletions (SCTCi019-B) in ALDH7A1 using CRISPR/Cas9
Imke M E Schuurmans, Ka M Wu, Clara D M van Karnebeek, Nael Nadif Kasri, Alejandro Garanto
Stem Cell Res, 71: 103173
Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing
Melita Kaltak, Zelia Corradi, Rob W J Collin, Jim Swildens, Frans P M Cremers
Hum Mol Genet. 2023 Oct 17;32(21):3078-3089
Comparative Clustering (CompaCt) of eukaryote complexomes identifies novel interactions and sheds light on protein complex evolution
Joeri van Strien, Felix Evers, Madhurya Lutikurti, Stijn L Berendsen, Alejandro Garanto, Geert-Jan van Gemert, Alfredo Cabrera-Orefice, Richard J Rodenburg, Ulrich Brandt, Taco W A Kooij, Martijn A Huynen
PLoS Comput Biol. 2023 Aug 7;19(8):e1011090
Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics
Haiyan Zhou, Virginia Arechavala-Gomeza, Alejandro Garanto
Nucleic Acid Ther. 2023 Aug;33(4):238-247
Generation of three isogenic control lines from patient-derived iPSCs carrying bi-allelic ABCA4 variants underlying Stargardt disease
Dyah W Karjosukarso, Femke Bukkems, Lonneke Duijkers, Nico Leijsten, Rob W J Collin
Stem Cell Res. 2023 Sep:71:103169
Generation of iPSC lines from three Stargardt patients carrying bi-allelic ABCA4 variants
Dyah W Karjosukarso, Femke Bukkems, Lonneke Duijkers, Nico Leijsten, Carel B Hoyng, Rob W J Collin
Stem Cell Res. 2023 Sep:71:103164
Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
Imke M E Schuurmans, Ka M Wu, Clara D M van Karnebeek, Nael Nadif Kasri, Alejandro Garanto
Stem Cell Res. 2023 Jun:69:103069
Evaluation of Sleep Quality and Fatigue in Patients with Usher Syndrome Type 2a
Jessie M Hendricks, Juriaan R Metz, Hedwig M Velde, Jack Weeda, Franca Hartgers, Suzanne Yzer, Carel B Hoyng, Ronald J E Pennings, Rob W J Collin, Myrthe H M Boss, Erik de Vrieze, Erwin van Wijk
Opthalmol Sci. 2023 May 5;3(4):100323
CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids
Tess A V Afanasyeva, Dimitra Athanasiou, Pedro R L Perdigao, Kae R Whiting, Lonneke Duijkers, Galuh D N Astuti, Jean Bennett, Alejandro Garanto, Jacqueline van der Spuy, Ronald Roepman, Michael E Cheetham, Rob W J Collin
Mol Ther Methods Clin Dev. 2023 May 17:29:522-531
In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis
Federica Conte, Angel Ashikov, Rachel Mijdam, Eline G P van de Ven, Monique van Scherpenzeel, Raisa Veizaj, Seyed P Mahalleh-Yousefi, Merel A Post, Karin Huijben, Daan M Panneman, Richard J T Rodenburg, Nicol C Voermans, Alejandro Garanto, Werner J H Koopman, Hans J C T Wessels, Marek J Noga, Dirk J Lefeber
Int J Mol Sci. 2023 May 4;24(9):8247
Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme
Siebren Faber, Olivier Mercey, Katrin Junger, Alejandro Garanto, Helen May-Simera, Marius Ueffing, Rob W J Collin, Karsten Boldt, Paul Guichard, Virginie Hamel, Ronald Roepman
JCI Insight. 2023 May 22;8(10):e169162
Exploring genotype-phenotype correlations in glutaric aciduria type 1
Imke M E Schuurmans, Bianca Dimitrov, Julian Schröter, Antonia Ribes, Rubén Pérez de la Fuente, Berta Zamora, Clara D M van Karnebeek, Stefan Kölker, Alejandro Garanto
J Inherit Metab Dis. 2023 May;46(3):371-390
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C
Melita Kaltak, Petra de Bruijn, Davide Piccolo, Sang-Eun Lee, Kalyan Dulla, Thomas Hoogenboezem, Wouter Beumer, Andrew R Webster, Rob W J Collin, Michael E Cheetham, Gerard Platenburg, Jim Swildens
Mol Ther Nucleic Acids. 2023 Feb 18:31:674-688
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C
Melita Kaltak, Petra de Bruijn, Davide Piccolo, Sang-Eun Lee, Kalyan Dulla, Thomas Hoogenboezem, Wouter Beumer, Andrew R Webster, Rob W J Collin, Michael E Cheetham, Gerard Platenburg, Jim Swildens
Mol Ther Nucleic Acids. 2023 Feb 18:31:674-688
Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction.
Janine Reurink, Nicole Weisschuh, Alejandro Garanto, ... , Erwin van Wijk, Susanne Roosing
HGG Advances. 2023 April;4(2)
Consensus guidelines for the design and in vitro preclinical efficacy testing N-of-1 exon skipping antisense oligonucleotides.
Annemeieke Aartsma-Rus, Alejandro Garanto, ... , Jonathan K Watts, Timothy W Yu
Nucleic Acid Therapeutics. 2023 Feb;33(1)
PDE6D mediates trafficking of prenylated protein NIM1K and UBL3 to primary cilia.
Siebren Faber, Stef JF Letteboer, ... , Rob WJ Collin, ... , Karsten Boldt, Ronald Roepman
Cells. 2023 Jan;12(2):31.
2022
Correction of the splicing defect caused by a recurrent variant in ABCA4 (c.769-784C>T) that underlies Stargardt disease.
Tomasz Z Tomkiewicz, Sara E. Nieuwenhuis, Frans P.M. Cremers, Alejandro Garanto, Rob WJ Collin
The predicted splicing variant c.11+5G>A in RPE65 leads to a reduction in mRNA expression in a cell-specific manner.
Irene Vázquez-Domínguez, Lonneke Duijkers, ... , Edwin M. van Oosten, ... Anita D.M. Hoogendoorn, ... , Rob WJ Collin, Susanne Roosing, Alejandro Garanto
Cells. 2022 Dec;11(24):3947.
How to proceed after 'negative' exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques.
Wortmann SB, Oud MM, ..., Garanto A, Hoischen A, ..., Vissers LELM, van Karnebeek CDM
Generation of an iPSC line (SCTCio14-A) and isogenic control line (SCTCio14-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene.
de Jong S, ..., Vázquez-Domínguez I, ..., I de Hollander A, Garanto A
Nature Medicine, 2022: Apr 4. doi: 10.1038/s41591-022-01755-w.
Generation of an iPSC line (SCTCio15-A) and isogenic control line (SCTCio15-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene.
de Jong S, ..., Vázquez-Domínguez I, ..., I de Hollander A, Garanto A
Identification of a Complex Allele in IMPG2 as a Cause of Adult-Onset Vitelliform Macular Dystrophy.
Vázquez-Domínguez I, Li CHZ, ..., Garanto A, ..., Roosing S
Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial.
Russell SR, Drack AV, Cideciyan AV, ..., Collin RWJ, Hoyng C, ..., Rodman D, Girach A
Nature Medicine, 2022: Apr 4. doi: 10.1038/s41591-022-01755-w.
Human Molecular Genetics, 00: 1-11 (ddac057)
PCARE requires coiled coil, RP62 kinase-binding and EVH1 domain-binding motifs for ciliary expansion.
Afanasyeva TAV, Schnellbach YT, Gibson TJ, Roepman R, Collin RWJ
Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.
Garanto A, Ferreira CR, Boon CJF, van Karnebeek CDM, Blau N
Molecular Genetics and Metabolism, 60: S1096-7192(22)00134-2
Stem Cell Research, 60: 102689
Generation of a patient-derived induced pluripotent cell line (SCTCi016-A) carrying a homozygous variant in RPE65.
Vázquez-Domínguez I, Kwint, M, ...,Cremers FPM, Collin RWJ, Roosing S, Garanto A
Methods in Molecular Biology; Antisense RNA Design, Delivery, and Analysis: Methods and Protocols, 2434: 321-332
Delivery of Antisense Oligonucleotides to the Mouse Retina.
Garanto A
Methods in Molecular Biology; Antisense RNA Design, Delivery, and Analysis: Methods and Protocols, 2434: 267-279
Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides.
Vázquez-Domínguez I, Garanto A
Methods in Molecular Biology; Antisense RNA Design, Delivery, and Analysis: Methods and Protocols, 2434: 145-165
Development and Use of Cellular Systems to Assess and Correct Splicing Defects.
Suárez-Herrera N, Tomkiewicz TZ, Garanto A, Collin RWJ
Methods in Molecular Biology; Antisense RNA Design, Delivery, and Analysis: Methods and Protocols, 2434: 33-49
Antisense RNA Therapeutics: A Brief Overview.
Arechavala-Gomeza V, Garanto A
2021
American Journal of Human Genetics, 108: 1-15
Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromuscularskeletal findings.​
Wilson MP, Garanto A, ..., Morava E, Lefeber DJ
Human Molecular Genetics, 2021
Systemic complement levels in patients with age-related macular degeneration carrying rare or low frequency variants in the CFH gene.​
de Jong S, de Breuk A, ..., Garanto A, ..., van den Heuvel LP, den Hollander AI
International Journal of Molecular Sciences, 22, 9154
Zebrafish as a Model to Evaluate a CRISPR/Cas-9-Based Exon Excision Approach as a Future Treatment Option for EYS-Associated Retinitis Pigmentosa.​
Schellens R, de Vrieze E, ..., Collin RWJ, van Wijk E
Cellular and Molecular Life Sciences, 2021
A look into retinal organoids: methods, analytical techniques, and applications.​
Afanasyeva TAV, Corral-Serrano JC, Garanto A, Roepman R, Cheetham ME, Collin RWJ
Human Mutation, 2021; 1-27
PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease.​
Peeters MHCA, ..., Hoyng CB, Cremers FPM, ..., Collin RWJ
Prog Retin Eye Res, 6;100987
Approaches for corneal endothelium regenerative medicine.​
Catala P, ..., Collin RWJ, ..., Dickman MM
International Journal of Molecular Science, 22(9), 4621
Antisense Oligonucleotides-Based Rescue of Aberrant Splicing Defects Caused by 15 Pathogenic Variants in ABCA4.​
Tomkiewicz TZ, Suárez-Herrera N, Cremers FPM, Collin RWJ, Garanto A
Delivery of oligonucleotide - based therapeutics: challenges and opportunities.​
Hammond SM, ..., Collin RWJ, ..., Garanto A, ..., Arechavala-Gomeza V
EMBO Molecular Medicine, 13, e13243
Implications of genetic variation in the complement system in age-related macular degeneration.​
de Jong Sarah, …, Garanto A, …, den Hollander A
Progress in Retinal and Eye Research, 2021, 100952
2020
The deubiquitinating enzyme ataxin-3 regulates ciliogenesis and phagocytosis in the retina. ​
Toulis V, …, Garanto A, Costa MdC, Marfany G
Cell Reports, 33: 108360
Detailed phenotyping and therapeutic strategies for intronic ABCA4 variants in Stargardt disease.
​
Khan M, Arno G, Fakin A, Parfitt DA, Dhooge PPA, Albert S, Bax, NM, Duijkers L, …, Garanto A, Collin RWJ
Molecular Therapy Nucleic Acids, 21: 412-427
PCARE and WASF3 regulate ciliary F-actin assembly that is required for the initiation of photoreceptor outer segment disk formation.
Corral-Serrano JC, Lamers IJC, van Reeuwijk J, Duijkers L, Hoogendoorn ADM, …, Garanto A, Roepman R, Collin RWJ
Proc Natl Acad Sci U S A, 18: 9922-9931
In or out? New insights on exon recognition through splice-site interdependency.
Khan M, Cornelis SS, Sangermano R, Post IJM, Janssen Groesbeek A, Amsu J, Glissen C, Garanto A, Collin RWJ, Cremers FPM
International Journal of Molecular Science, 21: E2300
Modeling ZNF408-associated FEVR in zebrafish results in abnormal retinal vasculature.
Karjosukarso DW, Ali Z, Peters TA, Zhang JQC, Hoogendoorn ADM, Garanto A, van Wijk E, Jensen LD, Collin RWJ
Investigative Ophthalmology & Visual Science, 61: 39
2019
P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
Timmermans-Spring E, Collin RWJ, Henkes A, Philipsen M, Mol JA
Oncotarget, 11: 573
RNA-based therapeutic strategies for inherited retinal dystrophies.
Garanto A
Advances in Experimental Medicine and Biology, 1185: 71-77
Molecular therapies for inherited retinal diseases - current standing, opportunities and challenges.
Vázquez-Domínguez I, Garanto A, Collin RWJ
Genes, 10: E654
Antisense oligonucleotide screening to optimize the rescue of the splicing Defect caused by the recurrent deep-intronic ABCA4 variant c.4539+2001G>A in Stargardt disease.
Garanto A, Duijkers L, Tomkiewicz TZ, Collin RWJ
Genes, 10: E452
Extending the Spectrum of EYS-Associated Retinal Disease to Macular Dystrophy.
Pierrache LHM, Messchaert M, Thiadens AAHJ, Haer-Wigman L, de Jong-Hesse Y, van Zelst-Stams WAG, Collin RWJ, Klaver CCW, van den Born LI
Investigative Ophthalmology & Visual Science, 60: 2049-2063
ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants.
Bauwens M, Garanto A, Sangermano R,..., Collin RWJ, Cremers FPM, Leroy BP, De Baere E
Genetics in Medicine, 21: 1761–1771
Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides.
Sangermano R, Garanto A, Khan M, ..., Albert S, Collin RWJ, Cremers FPM
Genetics in Medicine, 21: 1750-1761
2018
Clinical characterization of 66 patients with congenital retinal disease due to the deep-intronic c.2991+1655A>G mutation in CEP290.
Valkenburg D, van Cauwenbergh C, Lorenz B, ..., Leroy BP, van den Born LI, Collin RWJ
Investigative Ophthalmology & Visual Science, 59: 4384-4391
Detection and quantification of a KIF11 mosaicism in a subject presenting familial exudative vitreoretinopathy with microcephaly.
Karjosukarso DW, Cremers FPM, van Nouhuys CE, Collin RWJ
European Journal of Human Genetics, 26: 1819–1823
Eyes shut homolog is important for the maintenance of photoreceptor morphology and visual function in zebrafish.
Messchaert M, Dona M, Broekman S, Peters TA, Corral-Serrano JC, Slijkerman RWN, van Wijk E, Collin RWJ
PLoS One, 13: e0200789
An FEVR-associated mutation in ZNF408 alters the expression of genes involved in the development of vasculature.
Karjosukarso DW, van Gestel SHC, Qu J, Kouwenhoven EN, Duijkers L, Garanto A, Zhou H, Collin RWJ
Human Molecular Genetics, 27: 3519–3527
Antisense oligonucleotide-based splice correction of a deep-intronic mutation in CHM underlying choroideremia.
Garanto A, van der Velde-Visser SD, Cremers FPM, Collin RWJ
Advances in Experimental Medicine and Biology, 1074: 83-89
Antisense oligonucleotide-based splicing correction in individuals with Leber Congenital Amaurosis due to compound heterozygosity for the c.2991+1655A>G mutation in CEP290.
Duijkers L, van den Born LI, Neidhardt J, Bax NM, Pierrache LHM, Klevering BJ, Collin RWJ, Garanto A
International Journal of Molecular Science, 19: E753
Design and in vitro use of antisense oligonucleotides to correct pre-mRNA splicing defects in inherited retinal dystrophies.
Garanto A, Collin RWJ
Methods in Molecular Biology; Retinal Gene Therapy: Methods and Protocols, 1715: 61-78
ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease.
Sangermano R, Khan M, Cornelis SS, ..., Garanto A, ..., van den Born LI, Collin RWJ, Cremers FPM
Genome Research, 28: 100-110
EYS mutation update: in silico assessment of 271 reported and 26 novel variants in patients with retinitis pigmentosa.
Messchaert M, Haer-Wigman L, Khan MI, Cremers FPM, Collin RWJ
Human Mutation, 39: 177-186
bottom of page